TimesSquare Capital Management LLC grew its position in shares of Legend Biotech Co. (NASDAQ:LEGN – Get Rating) by 0.6% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 946,500 shares of the company’s stock after buying an additional 5,200 shares during the quarter. […]